It analyzes pathway-level variants such as GLP1R, FTO, MC4R, and TCF7L2 that describe your baseline metabolic biology, useful context for a provider conversation rather than a forecast of drug results
Medicina (Kaunas) 58(10):1382 Yang A, Wu H, Lau ESH, Zhang X, Shi M, Fan B, et al (2022) Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-year trends in 09 million adults with diabetes in Hong Kong (20022019)
GLP-1 Agonist Use and Side Effects in the United States ResearchPublished Aug 6, 2025 GLP-1 agonists are a class of medications that are prescribed to manage blood sugar for those with type 2 diabetes and to treat obesity
GLP-1 medications have already changed the way physicians treat type 2 diabetes and obesity, but little real-world data exist to compare the effectiveness of the two most common medications, noted Nick Stucky, VP of Truveta Research, in a Monday announcement
As such, this medication delivers dual advantages by aiding glycemic control while concurrently lessening potential complications linked with diabetes
